| Gene/Event | Cancer Type | Patient | Variant | Mutation Level |
|---|---|---|---|---|
| FLG2 | Breast Cancer | p143_p2 | Chr1:152326027:C>G | Private mutation |
| FLG2 | Breast Cancer | p143_p5 | Chr1:152326554:C>A | Trunk mutation |
| FLG2 | Breast Cancer | p143_p5 | Chr1:152324890:G>C | Private mutation |
| FLG2 | Colorectal Cancer | p001_PCRC01 | Chr1:152327032:C>T | Trunk mutation |
| FLG2 | Colorectal Cancer | p004_CRC_A02 | Chr1:152323926:T>G | Private mutation |
| FLG2 | Colorectal Cancer | p155_p229 | p.G680G | Private mutation |
| FLG2 | Colorectal Cancer | p155_p495 | p.S1036* | Private mutation |
| FLG2 | Esophageal Squamous Cell Carcinoma | p008_ESCC08 | p.E40V | Branch mutation |
| FLG2 | Esophageal Squamous Cell Carcinoma | p008_ESCC11 | p.G2102A | Branch mutation |
| FLG2 | Esophageal Squamous Cell Carcinoma | p008_ESCC13 | p.A818S | Trunk mutation |
| FLG2 | Esophageal Squamous Cell Carcinoma | p124_ESCC012 | p.S147* | Private mutation |
| FLG2 | Esophageal Squamous Cell Carcinoma | p124_ESCC012 | p.S775F | Private mutation |
| FLG2 | Esophageal Squamous Cell Carcinoma | p124_ESCC029 | p.Y583* | Private mutation |
| FLG2 | Esophageal Squamous Cell Carcinoma | p139_EC1020 | p.R1072H | Private mutation |
| FLG2 | Esophageal Squamous Cell Carcinoma | p139_EC1120 | p.S650G | Branch mutation |
| FLG2 | Gastric Adenocarcinoma | p011_MSS2 | p.H1667Q | Private mutation |
| FLG2 | Gastric Carcinoma | p106_GC02 | p.G965R | Trunk mutation |
| FLG2 | Gastric Carcinoma | p106_GC07 | p.T1410T | Private mutation |
| FLG2 | Gastric Carcinoma | p106_GC07 | p.G281G | Private mutation |
| FLG2 | Gastric Carcinoma | p106_GC09 | p.R1420R | Private mutation |
| FLG2 | Gastric Carcinoma | p106_GC09 | p.Q1343R | Private mutation |
| FLG2 | Gastric Carcinoma | p106_GC15 | p.S1273R | Private mutation |
| FLG2 | Gastric Carcinoma | p106_GC15 | p.S864R | Private mutation |
| FLG2 | Gastric Carcinoma | p106_GC15 | p.E1615D | Private mutation |
| FLG2 | Gastric Carcinoma | p106_GC15 | p.S1525R | Private mutation |
| FLG2 | Intrahepatic Cholangiocarcinoma | p159_Pat4 | p.S2268T | Trunk mutation |
| FLG2 | Hepatocellular Carcinoma | p061_P02 | Chr1:152329782:C>G | Private mutation |
| FLG2 | Hepatocellular Carcinoma | p157_p1 | p.H1406Q | Private mutation |
| FLG2 | Lung Adenocarcinoma | p017_472 | Chr1:152331245:T>A | Trunk mutation |
| FLG2 | Lung Adenocarcinoma | p083_X472 | - | Trunk mutation |
| FLG2 | Medulloblastoma | p072_MB1 | Chr1:152325479:G>A | Private mutation |
| FLG2 | Melanoma | p043_C | p.S717F | Trunk mutation |
| FLG2 | Melanoma | p043_F | p.S285L | Trunk mutation |
| FLG2 | Melanoma | p043_H | p.R1412K | Private mutation |
| FLG2 | Melanoma | p043_H | p.E359K | Private mutation |
| FLG2 | Ovarian Cancer | p065_patient | p.E1608K | Trunk mutation |
| FLG2 | Ovarian Cancer | p144_AOCS088 | p.G1413G | Private mutation |
| FLG2 | Prostate Cancer | p105_1027 | p.Q369X | Private mutation |
| FLG2 | Prostate Cancer | p164_P2 | p.S2377X | Private mutation |
| FLG2 | Urothelial Carcinoma | p031_WCM088 | p.D1320V | Private mutation |
| FLG2 | Urothelial Carcinoma | p142_p05 | - | Trunk mutation |
| FLG2 | Urothelial Carcinoma | p142_p25 | - | Private mutation |
| FLG2 | Urothelial Carcinoma | p142_p37 | - | Private mutation |